A federal court ruled against Pfizer last week in two of the three cases it filed against journals requesting confidential peer-review documents. The company lost against JAMA and the Archives of Internal Medicine, and is still waiting to hear on the decision for NEJM.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.